|
|
||||||||
1From the F. M. Kirby Center for Molecular Ophthalmology, Scheie Eye Institute, Philadelphia, Pennsylvania; the 2Graduate Program in Pharmacology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania; the 6Departments of Medicine, 3Pathology and Laboratory Medicine, 4Abramson Family Cancer Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania; and the 5Department of Ophthalmology, Scheie Eye Institute, Philadelphia, Pennsylvania.
| Abstract |
|---|
|
|
|---|
METHODS. Eyes from mice at postnatal day (P)7, during the peak of developmental apoptosis in the retina, were processed for TdT-dUTP terminal nick-end labeling (TUNEL) to determine whether Bax knockout or double Bax/Bak knockout causes a defect in developmental apoptosis. Adult (>2-month-old) eyes from wild-type, Bak-/-, Bax-/-, and Bax-/-Bak-/- mice were analyzed by histology and immunocytochemistry to identify persistent retinal cells.
RESULTS. Adult Bax-/-Bak-/- eyes showed significant increases in the number of inner retinal cells, with an almost complete absence of TUNEL-positive cell death at P7. Some of these persistent cells in the inner retina notably included rod photoreceptors that normally undergo apoptosis after failure to migrate to the outer retina. These inner nuclear layer (INL) rods contained markers of early rod differentiation: rod opsin, arrestin, and recoverin. However, they did not form ectopic outer segments or contain the associated markers ROM-1, peripherin-2, and RP1.
CONCLUSIONS. Bax and Bak are important for retinal development and are the first apoptotic factors identified as essential for developmental photoreceptor apoptosis. Future studies will investigate the potential role of Bax and Bak in mediating pathologic photoreceptor death.
Beyond this involvement in ocular development, apoptosis rarely occurs in a normal, healthy retina but has been implicated in both inherited and acquired retinal degenerations.4 5 6 The molecular pathogenesis of these retinal degenerations is still unclear, but apoptosis is the final common pathway in many retinal diseases, ranging from glaucoma to age-related macular degeneration, retinitis pigmentosa, and retinal detachment.5 7 8 9 10 11 12 13
The specific apoptotic factors involved in developmental apoptosis have only recently been investigated, demonstrating a role for Bcl-2 family members in ocular development. Transgenic overexpression of antiapoptotic Bcl-2 in the GCL and INL results in an adult retina with up to twice as many cells in these layers as in adult wild-type retinas.14 In addition, retinas deficient in proapoptotic Bax contain fewer TUNEL-positive INL and GCL neurons than do wild-type retinas at P7, the peak of developmental apoptosis, resulting in a corresponding increase in the thickness of these layers by adulthood.15 No study detected changes in photoreceptors.
It has been proposed that neurodegenerative disorders, including retinal degenerations, involve a pathologic reactivation of developmental apoptotic programs.16 Apoptotic factors involved in developmental regression of neurons may also mediate apoptosis in neurodegenerative diseases. Indeed, Bcl-2 overexpression, shown to substantially reduce the elimination of ganglion cells during development, rescues ganglion cell death induced by optic nerve axotomy.17
No apoptotic factor has yet been demonstrated to be involved in developmental photoreceptor apoptosis. In pathologic photoreceptor apoptosis, Bcl-2 overexpression mediates transient protection in several models of photoreceptor degenerations,18 suggesting that other Bcl-2 family members may also influence photoreceptor survival. However, Bax-deficiency does not rescue photoreceptor degeneration induced by a cGMP-phosphodiesterase mutation in the rd mouse.15 Clearly, there is a therapeutic need for improved understanding of the mechanisms underlying pathologic photoreceptor degenerations, an understanding likely to be advanced by the identification of apoptotic factors involved in developmental photoreceptor elimination.
We report that two proapoptotic Bcl-2 family members, Bax and Bak, are essential mediators of inner retinal apoptosis without which virtually all developmental apoptosis at P7 is absent. Bax-/-Bak-/- retinas retain inner retinal neurons, notably including rod photoreceptors in the INL. This is the first report of apoptotic factors involved in developmental photoreceptor regression.
| Materials and Methods |
|---|
|
|
|---|
All procedures conformed to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research, and the procedures were approved by the Institutional Animal Care and Use Committee of the University of Pennsylvania.
Histology and Morphometry
Fixed globes were rinsed in PBS, and eyecups were prepared by removing the anterior segment and lens, with careful attention to preservation of the vitreous. Eyecups were oriented and embedded in JB-4 plastic (Polysciences, Inc., Warrington, PA). Sections 1-µm-thick through the optic nerve head (ONH) were stained with 30% Richardsons methylene blue/azure II.
Digitized images of each section were acquired with a light microscope (Eclipse TE-300; Nikon, Inc., Melville, NY) and digital camera (Spot RT Slider; Diagnostic Instruments, Inc., Sterling Heights, MI; with ImagePro Plus software, ver. 4.1; Media Cybernetics, Silver Spring, MD) or with a second microscope (DMRE; Leica Microsystems, Inc., Bannockburn, IL) and camera (Orca C4742-95 Hamamatsu Corp., Bridgewater, NJ; with OpenLab software, ver. 2.2.0; Improvision, Inc., Boston, MA). The number of nuclei per column of each nuclear layer (ONL, INL, and GCL) were counted in triplicate at 200 µm intervals from 300 to 2000 µm from the ONH. The thickness of the outer plexiform layer (OPL) and inner plexiform layer (IPL) as well as total retinal thickness, from internal to external limiting membranes, were also measured in triplicate at the same intervals, using image analysis software (ImagePro Plus ver.4.1; Media Cybernetics) to calculate distances from manually set lengths.
Statistical Analysis
Analysis was performed by calculating means and standard errors (SEM) of each retinal layer from each genotype. The SEM was calculated from the generalized equation estimate, with adjustments for correlations among repeated measurements from the same eye.22 To examine differences among different genotypes, linear mixed models were fit using methods to account for the correlation among repeated measurements from the same eye. The models also included the distance from the optic nerve head and its interaction with genotype to explore whether measurements vary with distance from the ONH and whether the effect of distance is the same in all genotypes. When the overall F-test for any difference among the four genotypes was found to be significant, pair-wise differences among genotypes and their 95% confidence intervals were estimated from the mixed model. The probabilities for the significance of pair-wise differences were calculated with the multiple tests taken into consideration by the method of Tukey.23 All data analyses were performed on computer (SAS, ver. 8.0 (SAS Institute, Inc., Cary, NC).
TUNEL Analysis and Immunocytochemistry
Fixed globes were rinsed in PBS and prepared as eyecups, which were treated with 0.1% sodium borohydride, cryoprotected in 30% sucrose, and embedded in optimal cutting temperature compound (OCT; Tissue-Tek; Sakura Finetek, USA., Inc., Torrance, CA).24 Cryosections 10 µm thick were cut through the optic nerve head and stored at -20°C.
Some fixed globes were rinsed in PBS, dehydrated, and embedded in paraffin. Sections 5 µm thick were cut through the optic nerve head and stored at room temperature.
TUNEL analysis was performed on cryosections and paraffin-embedded sections from eyes harvested at P7, during the peak of retinal developmental apoptosis,1 using a commercial kit (Roche Diagnostics Corp., Indianapolis, IN). Nuclei were counterstained (blue) with 4',6'-diamino-2-phenylindole (DAPI; 1.5 µg/mL)supplemented mounting medium (Vectashield; Vector Laboratories, Inc.). Sections were analyzed by fluorescence microscopy, and digitized images were acquired.
Immunocytochemistry was performed as published.24 Cell-specific markers were anti-glial fibrillary acidic protein (Z0334, 1:500; Dako Corp., Carpinteria, CA); anti-
aminobutyric acid (1:2000; Protos Biotech Corp., New York, NY); anti-glycine (1:100; Robert Marc, University of Utah, Salt Lake City); anti-calbindin-D (C8666, 1:250; Sigma-Aldrich Corp., St. Louis, MO); anti-cellular retinaldehyde binding protein (1:500; John Saari, University of Washington, Seattle); PNA-rhodamine (RL1072, 1:100; Vector Laboratories, Inc.); anti-BrdU (G3G4, 1:50; Developmental Studies Hybridoma Bank, Iowa City, IA); anti-L7 (1:250, James Morgan, St. Judes Children Research Hospital, Memphis, TN); mouse anti-rod opsin (4D2, 1:80; Robert Molday, University of British Columbia, Vancouver, Canada); sheep anti-rod opsin (1:1000; David Papermaster, University of Connecticut, Farmington, CT); anti-arrestin (A9C6, 1:1000; Larry Donoso, Wills Eye Institute, Philadelphia, PA); anti-recoverin (P26, 1:1000; Alexander Dizhoor, Kresge Eye Institute, Detroit, MI); anti-blue cone opsin (JH455, 1:5000; Jeremy Nathans, Johns Hopkins University, Baltimore, MD); anti-peripherin-2 (Per-5H2, 1:30; Robert Molday); anti-ROM-1 (1:20; Roderick McInnes, University of Toronto, Ontario, Canada), and anti-RP1 (1:1000; Qin Liu, Scheie Eye Institute, Philadelphia, PA). Control sections were treated identically but with omission of primary antibody. Secondary antibodies (donkey anti-rabbit, anti-mouse, anti-guinea pig, anti-chicken) were labeled with Cy-2 (green) or Cy-3 (red; Jackson ImmunoResearch Laboratories, Inc., West Grove, PA). Nuclei were counterstained with DAPI (µg/mL)supplemented mounting medium (Vectashield; Vector Laboratories, Inc.). Sections were analyzed by fluorescence microscopy, and digitized images were acquired as described earlier.
| Results |
|---|
|
|
|---|
|
The thickness of each nuclear layer was measured as the number of nuclei per column, to avoid the confounding effects of variable fixation or glial expansion. The thickness of each plexiform layer and total retinal thickness were also measured. We confirmed statistically significant increases in Bax-/- inner retinas compared with wild-type15 (Fig. 2) . Bax-/-Bak-/- retinas exhibited further increases in inner retinal thickness compared with Bax-/- (GCL: P < 0.005; INL: P < 0.001; IPL: P < 0.01). There were no significant differences in the outer retina among all genotypes. In addition, Bak-/- retinas were not statistically different from wild-type in all measured parameters. As the results were not influenced by distance from the ONH, the thickness of each layer is represented by a single value, the mean of all measurements in each retina.
|
|
Retinas were labeled with markers for rods and cones. PNA-rhodamine labeling for cones revealed no differences among genotypes (data not shown). Rods labeled with anti-rod opsin and anti-rod arrestin had positive outer segments and cell bodies in the ONL.25 26 Bax-/-Bak-/- retinas labeled with anti-rod opsin or anti-arrestin unexpectedly showed rods in the outer part of the INL (Figs. 4 5) . These rods were present in all Bax-/-Bak-/- retinas, but not in retinas of any of the other genotypes. The INL rod cell bodies had no outer segments in the INL, but some had short processes (Figs. 4 5 7) .
|
|
|
|
A subset of these INL cells had elongated cell bodies and was positive for recoverin only (Figs. 7A 7B 7C 7D 7E 7F , white arrowheads), corresponding to the normal number of cone bipolar cells, which do not express rod opsin or arrestin. We also identified arrestin-positive INL cells with undetectable levels of recoverin (Figs. 7D 7E 7F ; yellow arrows) and rod-opsin (Figs. 7G 7H 7I ; yellow arrows) as well as cells positive for rod opsin but not recoverin (not shown) or arrestin (Figs. 7G 7H 7I ; white arrowhead).
Anti-arrestin has been reported to label blue cones in primate retinas,29 but the INL cells positive only for arrestin were not blue cones, as labeling Bax-/-Bak-/- retinas with anti-blue cone opsin did not reveal any blue cones in the INL (not shown). INL rods in Bax-/-Bak-/- retinas were negative for ROM-1 or peripherin-2, markers of differentiated outer segments,30 31 and for RP1, a protein in the photoreceptor connecting cilia32 (not shown).
Effect of Ongoing Proliferation on the Number of Cells
To examine whether the increase in number of cells in the inner retina was due to deficient apoptosis or to an ongoing increase in proliferation beyond P11, the age by which all retinal neurons have become postmitotic,33 34 Bax-/-Bak-/- and control mice were pulsed with BrdU at 3 or 8 weeks of age. The brains of mice pulsed at 8 weeks showed increased BrdU-incorporation within cells in the periventricular zones of Bax-/-Bak-/- brains compared with wild-type brains, as detected by anti-BrdU labeling (Lindsten T, Golden J, Thompson CB, unpublished data, 2002). Sections of these brains were used as the positive control in parallel with retina sections from the same mice, and no BrdU incorporation was detected in the Bax-/-Bak-/- retinas (not shown). The thymus of 3-week-old Bax-/-Bak-/- mice incorporated BrdU (Lindsten T, Golden J, Thompson CB, unpublished data, 2002), and anti-BrdU labeling of whole eyes demonstrated BrdU-positive cells in the basal layer of the corneal epithelium, but not in the retinas (not shown). Absence of BrdU incorporation in Bax-/-Bak-/- retinas at these two time points, both shortly after and significantly after retinal neurons become postmitotic, together with the absence of TUNEL label, indicates that the increased inner retinal cells are due to defective developmental apoptosis and not ongoing proliferation.
| Discussion |
|---|
|
|
|---|
In retinas of all genotypes examined, trilaminar retinal architecture characteristic of mature, wild-type retinas was preserved, although histologic comparison of retinas revealed increased numbers of neurons in the INL and GCL of Bax-/-Bak-/- retinas compared with Bax-/-, Bak-/-, and wild-type retinas. Increased thickness of the IPL, which contains processes of cells with nuclei in the GCL and INL, was consistent with increased GCL and INL cells. No differences were found in the OPL or ONL of any genotype.
Consistent with an increased number of cells, Bax-/- and Bax-/-Bak-/- retinas had fewer TUNEL-positive cells than did wild-type retinas at P7, the peak of developmental apoptosis in the rodent retina.1 In Bax-/-Bak-/- P7 retinas only, developmental cell death was almost completely absent, with fewer than one TUNEL-positive cell per retinal section, supporting a pivotal role for Bax and Bak in developmental elimination of retinal cells.
These findings are consistent with previous reports of preserved retinal architecture and increased inner retinal thickness in Bax-/- and Bcl-2 transgenic mice, highlighting the importance of the Bcl-2 family in late retinal development. Recently, quantitative analysis of murine retinas overexpressing Bcl-2 driven by a neuron-specific enolase promoter14 revealed neuron preservation similar to our Bax-/-Bak-/- retinas. Both have approximate doubling of inner retinal thickness with an approximately 50% increase in total retinal thickness.
Our histologic results suggest that only cells of the INL and GCL are affected by the absence of Bax and/or Bak expression. Using immunocytochemistry with cell type- or class-specific markers (not shown), we observed increases in the number of several inner retinal cell types, without a preponderance of any particular type, as previously described in the Bax-/- retina.15 The presence of ectopic INL rods expressing rod opsin, arrestin, and recoverin in Bax-/-Bak-/- retinas was novel. In normal retinal development, as the OPL emerges at P5, it divides the population of developing rods approximately in half. During the ensuing 7 days, the 40% of rods situated in the inner aspect of the OPL migrate across the OPL into the ONL.1 Those that are unable to migrate successfully into the ONL transiently remain in the INL until, in the normal retina, these ectopic INL rods undergo apoptosis, with maximum cell death at P7 and elimination of all INL rods by approximately 3 weeks after birth.1 The absence of TUNEL-positive cells in the Bax-/-Bak-/- retinas at P7, the peak of INL rod apoptosis, suggests that the ectopic rods are present in the 2- to 3-month-old adult Bax-/-Bak-/- INL because they fail to undergo developmental apoptosis. Because in Bax-/- single knockouts and Bak-/- single knockouts, but not in double knockouts, the INL rods are eliminated during development, either Bax or Bak is necessary for INL rod apoptosis.
It is possible that Bax and Bak do not act autonomously on these INL rods but rather that these ectopic rods survive in Bax-/-Bak-/- retinas for alternative reasons, perhaps because of altered trophic interactions resulting from increased numbers of other cell types. We believe this possibility is unlikely, given that Bax-/- retinas also retain many INL cells yet do not have ectopic rods. To determine whether INL rod survival is cell intrinsic or extrinsic, we will generate for future studies conditional Bax/Bak knockout mice lacking Bax and Bak only in rods.
Double labeling Bax-/-Bak-/- retinas with combinations of anti-rod opsin, -arrestin, and -recoverin revealed that most of the INL cells are rods coexpressing these three rod markers. A subpopulation of INL cells contained only recoverin and another subset contained only arrestin. A small number of cells contained rod opsin but not the other rod markers. Because recoverin is normally expressed in cone bipolar cells of the INL, the cells positive for only recoverin are most likely cone bipolar cells, consistent with their distinct morphologic features. The anti-arrestin antibody used in the current study has been reported to detect primate blue cones in addition to rods,29 but labeling with a blue conespecific antibody did not reveal ectopic INL blue cones in Bax-/-Bak-/- retinas. In an in vitro culture system of dissociated primary rat retinal neurons cultured at P1 to P2, rod opsin- and arrestin-positive cells lacking recoverin were identified at P14 to P2037 and believed to have lost recoverin expression. Perhaps, similarly, a subset of the ectopic INL rods loses expression of arrestin, rod opsin, and/or recoverin.
It is interesting that the INL rods, while persistent into adulthood in Bax-/-Bak-/- mice, were less numerous at 8 months than at 2 to 3 months, as determined by the decreased number of 4D2-positive INL cells at 8 months (not shown) and dark INL nuclei characteristic of rods (Figs. 1D 1E) . Either these ectopic photoreceptors eventually die, or they differentiate into another cell class, such as bipolar cells, as previously documented in vitro.38
The INL rods appear unable to differentiate appropriately in their ectopic location and form outer segments, possibly as a result of inadequate proximity to the retinal pigment epithelium.39 Although it is formally possible that these ectopic rods have normally positioned outer segments, their short processes do not appear to exit the INL. We did not detect other markers of differentiated rodsnamely, the outer segment proteins ROM-1 and peripherin-2 and the connecting cilium protein RP1 in the INL rods. During development of ferret retina, rod opsin, arrestin, and recoverin are expressed early, whereas ROM-1 and peripherin-2 are expressed later, coincident with outer segment differentiation.40 The Bax-/-Bak-/- ectopic rods may represent a population of photoreceptors that have undergone initial but incomplete differentiation.
We have identified Bax and Bak as overlapping, essential mediators of retinal neuron regression, notably including at least a subset of rod photoreceptors. Most normal developmental rod elimination occurs within these INL rods, as very few ONL rods undergo apoptosis1 ; blocked apoptosis in this population is unlikely to result in a measurable excess of cells in the ONL. It is thus possible that elimination of both Bax and Bak preserves ONL rods as well, but beyond detectable levels. Bax and Bak, therefore, may be involved in developmental regression of retinal cells of all layers, including ONL rods, consistent with a previous finding of Bax immunolocalization in wild-type P16 retinas in the GCL, INL, and rod inner segments.41
Bax and Bak are the first apoptotic factors shown to be involved in developmental photoreceptor apoptosis. If degenerative diseases represent pathologic reactivation of developmental apoptosis, as previously proposed for Alzheimers and Parkinsons diseases and retinal degenerations,16 42 Bax and Bak may also mediate photoreceptor degeneration.
Although transgenic overexpression of Bax in photoreceptors results in extensive photoreceptor cell death,41 Bax deficiency did not rescue photoreceptor degeneration in cGMP-phosphodiesterasedeficient rd mice.15 Bax-/- retinas, however, did not have altered photoreceptor apoptosis during development. The finding that Bax-/-Bak-/- retinas, but not Bax-/- or Bak-/- retinas, retained photoreceptors normally fated to die during development suggests that Bak can compensate for Bax-deficiency. Deficiency in both Bax and Bak may rescue photoreceptors, where Bax-deficiency alone is inadequate.
Bcl-2 overexpression, in contrast, partially protects photoreceptors from pathologic degeneration.18 Bcl-2 protection, however, is variable and most important, even in the presence of transient rescue, Bcl-2 overexpression alone can be toxic to ONL photoreceptors.43 Targeting Bax/Bak rather than Bcl-2 is attractive because, like Bcl-2, Bax and Bak regulate mitochondrial membrane potential, which is disrupted in most apoptotic programs. However, unlike Bcl-2 overexpression, deficiency of Bax and Bak is not toxic to ONL photoreceptors, even at 8 months (Fig. 1E) . Future studies will test the hypothesis that Bax and Bak are essential for pathologic reactivation of apoptosis in photoreceptor and other retinal degenerations such that elimination of Bax and Bak functions may constitute a therapeutic strategy to protect photoreceptors and retain vision.
| Acknowledgements |
|---|
| Footnotes |
|---|
Submitted for publication October 31, 2002; revised December 20, 2002; accepted January 5, 2003.
Disclosure: P. Hahn, None; T. Lindsten, None; G.-S. Ying, None; J. Bennett, None; A.H. Milam, None; C.B. Thompson, None; J.L. Dunaief, None
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C.
1734 solely to indicate this fact.
Corresponding author: Joshua L. Dunaief, 305 Stellar-Chance Labs, 422 Curie Boulevard, Philadelphia, PA 19104; jdunaief{at}mail.med.upenn.edu.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
F. Doonan, M. Donovan, V. Gomez-Vicente, P. Bouillet, and T. G. Cotter Bim Expression Indicates the Pathway to Retinal Cell Death in Development and Degeneration J. Neurosci., October 3, 2007; 27(40): 10887 - 10894. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Hahn, T. Lindsten, M. Tolentino, C. B. Thompson, J. Bennett, and J. L. Dunaief Persistent Fetal Ocular Vasculature in Mice Deficient in Bax and Bak Arch Ophthalmol, June 1, 2005; 123(6): 797 - 802. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Lindsten, W.-X. Zong, and C. B. Thompson Defining the Role of the Bcl-2 Family of Proteins in the Nervous System Neuroscientist, February 1, 2005; 11(1): 10 - 15. [Abstract] [PDF] |
||||
![]() |
C. J. Zeiss, J. Neal, and E. A. Johnson Caspase-3 in Postnatal Retinal Development and Degeneration Invest. Ophthalmol. Vis. Sci., March 1, 2004; 45(3): 964 - 970. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Yang, D. Bula, J. G. Arroyo, and D. F. Chen Preventing Retinal Detachment-Associated Photoreceptor Cell Loss in Bax-Deficient Mice Invest. Ophthalmol. Vis. Sci., February 1, 2004; 45(2): 648 - 654. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |